Cargando…
Prognostic value of changes in high-sensitivity cardiac troponin T beyond biological variation in stable outpatients with cardiovascular disease: a validation study
OBJECTIVE: To evaluate the prognostic implications of longitudinal long-term changes beyond the biological variation of high-sensitivity cardiac troponin T (hs-cTnT) in outpatients with stable or asymptomatic cardiovascular disease (CV) and to assess possible differences in the prognostic value whil...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873128/ https://www.ncbi.nlm.nih.gov/pubmed/34694435 http://dx.doi.org/10.1007/s00392-021-01952-6 |
_version_ | 1784657396950368256 |
---|---|
author | Biener, Moritz Giannitsis, Evangelos Hogrefe, Katharina Mueller-Hennessen, Matthias Fröhlich, Hanna Katus, Hugo A. Frey, Norbert Frankenstein, Lutz Täger, Tobias |
author_facet | Biener, Moritz Giannitsis, Evangelos Hogrefe, Katharina Mueller-Hennessen, Matthias Fröhlich, Hanna Katus, Hugo A. Frey, Norbert Frankenstein, Lutz Täger, Tobias |
author_sort | Biener, Moritz |
collection | PubMed |
description | OBJECTIVE: To evaluate the prognostic implications of longitudinal long-term changes beyond the biological variation of high-sensitivity cardiac troponin T (hs-cTnT) in outpatients with stable or asymptomatic cardiovascular disease (CV) and to assess possible differences in the prognostic value while using reference change value (RCV) and minimal important differences (MID) as metric for biological variation. METHODS: Hs-cTnT was measured at index visit and after 12 months in outpatients presenting for routine follow-up. The prognostic relevance of a concentration change of hs-cTnT values exceeding the biological variation defined by RCV and MID of a healthy population within the next 12 months following the stable initial period was determined regarding three endpoints: all-cause mortality (EP1), a composite of all-cause mortality, non-fatal myocardial infarction and stroke (EP2), and a composite of all-cause mortality, non-fatal myocardial infarction, stroke, hospitalization for acute coronary syndrome (ACS) or decompensated heart failure, and planned and unplanned percutaneous coronary interventions (PCI, EP3). RESULTS: Change in hs-cTnT values exceeding the biovariability defined by MID but not by RCV discriminated a group with a higher cardiovascular risk profile. Changes within MID were associated with uneventful course (NPV 91.6–99.7%) while changes exceeding MID were associated with a higher occurrence of all endpoints within the next 365 days indicating a 5.5-fold increased risk for EP 1 (p = 0.041) a 2.4-fold increased risk for EP 2 (p = 0.049) and a 1.9-fold increased risk for EP 3 (p < 0.0001). CONCLUSIONS: In stable outpatients MID calculated from hs-cTnT changes measured 365 ± 120 days apart are helpful to predict an uneventful clinical course. CLINICAL TRIALS IDENTIFIER: NCT01954303. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00392-021-01952-6. |
format | Online Article Text |
id | pubmed-8873128 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-88731282022-03-02 Prognostic value of changes in high-sensitivity cardiac troponin T beyond biological variation in stable outpatients with cardiovascular disease: a validation study Biener, Moritz Giannitsis, Evangelos Hogrefe, Katharina Mueller-Hennessen, Matthias Fröhlich, Hanna Katus, Hugo A. Frey, Norbert Frankenstein, Lutz Täger, Tobias Clin Res Cardiol Original Paper OBJECTIVE: To evaluate the prognostic implications of longitudinal long-term changes beyond the biological variation of high-sensitivity cardiac troponin T (hs-cTnT) in outpatients with stable or asymptomatic cardiovascular disease (CV) and to assess possible differences in the prognostic value while using reference change value (RCV) and minimal important differences (MID) as metric for biological variation. METHODS: Hs-cTnT was measured at index visit and after 12 months in outpatients presenting for routine follow-up. The prognostic relevance of a concentration change of hs-cTnT values exceeding the biological variation defined by RCV and MID of a healthy population within the next 12 months following the stable initial period was determined regarding three endpoints: all-cause mortality (EP1), a composite of all-cause mortality, non-fatal myocardial infarction and stroke (EP2), and a composite of all-cause mortality, non-fatal myocardial infarction, stroke, hospitalization for acute coronary syndrome (ACS) or decompensated heart failure, and planned and unplanned percutaneous coronary interventions (PCI, EP3). RESULTS: Change in hs-cTnT values exceeding the biovariability defined by MID but not by RCV discriminated a group with a higher cardiovascular risk profile. Changes within MID were associated with uneventful course (NPV 91.6–99.7%) while changes exceeding MID were associated with a higher occurrence of all endpoints within the next 365 days indicating a 5.5-fold increased risk for EP 1 (p = 0.041) a 2.4-fold increased risk for EP 2 (p = 0.049) and a 1.9-fold increased risk for EP 3 (p < 0.0001). CONCLUSIONS: In stable outpatients MID calculated from hs-cTnT changes measured 365 ± 120 days apart are helpful to predict an uneventful clinical course. CLINICAL TRIALS IDENTIFIER: NCT01954303. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00392-021-01952-6. Springer Berlin Heidelberg 2021-10-25 2022 /pmc/articles/PMC8873128/ /pubmed/34694435 http://dx.doi.org/10.1007/s00392-021-01952-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Biener, Moritz Giannitsis, Evangelos Hogrefe, Katharina Mueller-Hennessen, Matthias Fröhlich, Hanna Katus, Hugo A. Frey, Norbert Frankenstein, Lutz Täger, Tobias Prognostic value of changes in high-sensitivity cardiac troponin T beyond biological variation in stable outpatients with cardiovascular disease: a validation study |
title | Prognostic value of changes in high-sensitivity cardiac troponin T beyond biological variation in stable outpatients with cardiovascular disease: a validation study |
title_full | Prognostic value of changes in high-sensitivity cardiac troponin T beyond biological variation in stable outpatients with cardiovascular disease: a validation study |
title_fullStr | Prognostic value of changes in high-sensitivity cardiac troponin T beyond biological variation in stable outpatients with cardiovascular disease: a validation study |
title_full_unstemmed | Prognostic value of changes in high-sensitivity cardiac troponin T beyond biological variation in stable outpatients with cardiovascular disease: a validation study |
title_short | Prognostic value of changes in high-sensitivity cardiac troponin T beyond biological variation in stable outpatients with cardiovascular disease: a validation study |
title_sort | prognostic value of changes in high-sensitivity cardiac troponin t beyond biological variation in stable outpatients with cardiovascular disease: a validation study |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873128/ https://www.ncbi.nlm.nih.gov/pubmed/34694435 http://dx.doi.org/10.1007/s00392-021-01952-6 |
work_keys_str_mv | AT bienermoritz prognosticvalueofchangesinhighsensitivitycardiactroponintbeyondbiologicalvariationinstableoutpatientswithcardiovasculardiseaseavalidationstudy AT giannitsisevangelos prognosticvalueofchangesinhighsensitivitycardiactroponintbeyondbiologicalvariationinstableoutpatientswithcardiovasculardiseaseavalidationstudy AT hogrefekatharina prognosticvalueofchangesinhighsensitivitycardiactroponintbeyondbiologicalvariationinstableoutpatientswithcardiovasculardiseaseavalidationstudy AT muellerhennessenmatthias prognosticvalueofchangesinhighsensitivitycardiactroponintbeyondbiologicalvariationinstableoutpatientswithcardiovasculardiseaseavalidationstudy AT frohlichhanna prognosticvalueofchangesinhighsensitivitycardiactroponintbeyondbiologicalvariationinstableoutpatientswithcardiovasculardiseaseavalidationstudy AT katushugoa prognosticvalueofchangesinhighsensitivitycardiactroponintbeyondbiologicalvariationinstableoutpatientswithcardiovasculardiseaseavalidationstudy AT freynorbert prognosticvalueofchangesinhighsensitivitycardiactroponintbeyondbiologicalvariationinstableoutpatientswithcardiovasculardiseaseavalidationstudy AT frankensteinlutz prognosticvalueofchangesinhighsensitivitycardiactroponintbeyondbiologicalvariationinstableoutpatientswithcardiovasculardiseaseavalidationstudy AT tagertobias prognosticvalueofchangesinhighsensitivitycardiactroponintbeyondbiologicalvariationinstableoutpatientswithcardiovasculardiseaseavalidationstudy |